Cargando…
Positron emitting (18)F-2-deoxy-2-fluoro-D-glucose: potential hot new therapy
Preclinical studies suggest that (18)F-2-deoxy-2-fluoro-D-glucose ((18)F-FDG) kills breast cancer cells without significant marrow toxicity or parenchymal toxicity. Radiation dose calculations estimated from fluorodeoxyglucose positron emission tomography images in women with metastatic disease indi...
Autores principales: | Mortimer, Joanne E, Taylor, Marie E |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2003
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC314419/ https://www.ncbi.nlm.nih.gov/pubmed/14580251 |
Ejemplares similares
-
(18)F-fluoro-2-deoxy-D-glucose positron emission tomography findings of neurolymphomatosis
por: Jung, Yun Hwa, et al.
Publicado: (2014) -
Comparison of Positron Emission Tomography Using 2-[(18)F]-fluoro-2-deoxy-D-glucose and 3-deoxy-3-[(18)F]-fluorothymidine in Lung Cancer Imaging
por: Wang, Fu-Li, et al.
Publicado: (2016) -
2-deoxy-2[(18)F]fluoro-D-glucose positron emission tomography–computed tomography in rheumatological diseases
por: Subesinghe, Manil, et al.
Publicado: (2021) -
Evaluation of Shoulder Disorders by 2-[F-18]-fluoro-2-deoxy-D-glucose Positron Emission Tomography and Computed Tomography
por: Moon, Young Lae, et al.
Publicado: (2010) -
Appearance of Adrenal Myelolipomas on 2-deoxy-2-((18)F) fluoro-D-glucose Positron Emission Tomography-Computed Tomography
por: Rowe, Steven P., et al.
Publicado: (2017)